Dianthus Therapeutics Inc...

NASDAQ: DNTH · Real-Time Price · USD
20.71
0.46 (2.27%)
At close: Aug 15, 2025, 3:59 PM
20.74
0.14%
After-hours: Aug 15, 2025, 04:10 PM EDT

Dianthus Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-114.75M -100.73M -84.97M -67.09M -56.68M -42.36M -57.78M -57.33M -58.63M -72.62M -66.4M -75.58M -76.94M -76.6M -71.14M -70.01M -70.26M -72.41M
Depreciation & Amortization
223K 235K 209K 234K 340K 313K 1.41M 1.36M 2.55M 3.66M 3.67M 4.15M 3.47M 2.76M 2.02M 1.98M 1.94M 1.96M
Stock-Based Compensation
18.78M 16.17M 12.89M 9.7M 7.04M 4.4M 2.9M 2.69M 1.51M 1.05M 2.42M 4.09M 7.89M 10.02M 10.31M 10.46M 9.02M 9.39M
Other Working Capital
6.69M 5.53M 6.06M 7.17M 4.84M 7.19M 3.93M 6.47M -4.5M -5.04M -3.76M -3.18M -3.4M -1.61M -806K -288K 1.53M -1.72M
Other Non-Cash Items
-12.34M -11.64M -10.26M -9.15M 2.27M -226K 15.72M 16.79M 15.59M 25.24M 12.86M 15.44M 16.9M 13.82M 11.09M 8.98M 4.09M 472K
Deferred Income Tax
n/a n/a n/a 944K 944K -66K -66K -1.01M -4.41M -10.03M -10.03M -10.03M -6.63M n/a n/a n/a n/a n/a
Change in Working Capital
20.54M 17.77M 16.62M 15.45M 6.26M 5.9M 4.86M 7.56M -3.37M -6.02M -2.19M -2.49M -3.12M 710K -1.53M -791K 718K -3.55M
Operating Cash Flow
-87.56M -78.19M -65.51M -49.92M -39.83M -31.84M -36.86M -33.86M -49.16M -59.47M -59.25M -66.09M -66.35M -62.5M -59.53M -57.57M -57.94M -64.14M
Capital Expenditures
-126K -97K -105K -84K 86K 82K -131K -150K -453K -561K -343K -329K -1.3M -1.28M -1.26M -1.46M -351K -276K
Cash Acquisitions
n/a n/a n/a n/a -5.38M -1.51M n/a -127K 5.25M 1.38M -127K n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-486.86M -460.56M -413.71M -331.86M -74.94M -77.9M -67.19M -55.6M -53.77M -44M -74.35M -105.03M -85.42M -85.42M -45.31M -90.76M -90.76M -90.76M
Sales Maturities Of Investments
245.75M 194.14M 127M 60M 50.78M 57.78M 77.78M 61.78M 87M 72M 37M 70M 52.5M 82.5M 90M 75M 77.5M 62.5M
Other Investing Acitivies
-196K -196K -196K -196K n/a 10.01M 10.01M 10.14M 10.14M 127K 127K n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-241.23M -266.51M -286.81M -271.94M -29.45M -11.75M 20.25M 15.82M 47.95M 28.94M -37.7M -35.35M -34.23M -4.21M 43.43M -17.22M -13.61M -28.54M
Debt Repayment
n/a n/a n/a n/a 15.64M 15.64M n/a n/a -15.64M -15.64M n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a -217.58M -229.73M -234.59M -168.15M 49.42M 61.57M 63.36M -3.08M -3.08M -3.08M n/a n/a n/a n/a n/a n/a n/a
Financial Cash Flow
40.7M 37.94M 255.62M 211.08M 364.86M 367.06M 133.57M 138.55M -12.76M -12.71M 2.93M 2.94M 376K 89.18M 89.6M 90.66M 90.29M 67.03M
Net Cash Flow
-300.93M -319.61M -109.53M -123.61M 251.54M 279.42M 74.7M 78.14M -12.31M -41.58M -94.14M -98.51M -101.98M 18.92M 69.94M 12.3M 16.97M -25.64M
Free Cash Flow
-100.36M -90.97M -78.28M -62.67M -39.74M -31.76M -36.99M -34.01M -49.62M -60.03M -59.6M -66.42M -67.65M -63.78M -60.8M -59.04M -58.29M -64.42M